Key result
Adipokines serve as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes.
Why the study?
To summarize studies from a Special Issue and discuss novel insights into adipokines as diagnostic biomarkers and therapeutic targets in diabetes and obesity.
Adipokines are highlighted as important diagnostic biomarkers and therapeutic targets in the management of obesity and type 2 diabetes.
Adipokines may inform diabetes biomarkers and targets; leaves open clinical translation pending prospective trials.
The Special Issue "Pathogenetic and Therapeutic Significance of Adipokines in Diabetes" focused on adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes. Experts discussed the pathological role of adipokines in their studies associated with diabetes. It provided new insights into the role of adipokines in diabetes. In this commentary and review, these studies will be summarized and the novel roles of adipokines will be discussed. This will also confirm the role of adipokines as biomarkers for diagnosis and prediction, and as therapeutic targets of diabetes and its related pathogenic phenomena.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2019) conducted a review in Diabetes and obesity. Adipokines was evaluated. Adipokines serve as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: